What is TGTX's current stock price?

As of now, TGTX is trading at $31.11, with a daily change of +2.67%.

What are the risks associated with TGTX stock?

TGTX Key risk is its Moderate, .

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

TGTX Stock Analysis & IQ Rating | TG Therapeutics

TGTX

TG Therapeutics

$31.11

+$0.81 | +2.67%

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

52W High

$ 46.48

MKT CAP

$ 4.89B

52W Low

$ 25.28

VOL

$ 1.35M

P/E Ratio

11.2

AVG VOL

$ 1.87M

RSI

36.13

TREND

Sideways

TGTX Stock IQ

Login to see TG Therapeutics (TGTX) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

TGTX Target Price

Login to display

Strengths

TGTX Rewards

Earnings are forecast to grow

TGTX Rewards

Expands stock buyback program

Chart

$34.22 (-9.09%)

$28.08 (+10.79%)

$35.17 (-11.54%)

$34.55 (-9.96%)

1year

6month

3month

1month

TGTX Risk Level

TGTX has Moderate risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Risks Indicators

Beta greater than 1.0

Moderate

LOW

HIGH

TGTX Analysts Opinion

TGTX overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

TGTX Analysts Opinion

TGTX Analysts opinion is negative and it remained unchanged from the past 3 months

TGTX Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential.

75%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

NA

0%

100%

TGTX Street Sentiment

TGTX Street Sentiment is extremely bullish and have positive views on the near-term outlook

TGTX Performance Sentiment

Sentiments overview associated with TGTX events and the stock performance.

75%

19%

Positive

Negative

12 out of 16
events present

3 out of 16
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$33.26

Resistance
Price

$32.84

Current Price Range

$35.57

Show methods +

TGTX Latest Analysis +

RSI Alert: TG Therapeutics (TGTX) Now Oversold. Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which me

Mon Nov 10, 2025

$30.34 | -6.02%

Technical

TG Therapeutics Crumbles After Roche Unveils Its Unprecedented Test Results.

Mon Nov 10, 2025

$30.34 | -6.02%

Activity

Momentum

Why TG Therapeutics (TGTX) is a Top Growth Stock for the Long-Term. The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Heres why you should take advantage.

Wed Nov 5, 2025

$34.04 | +0.68%

Potential

TGTXs Q3 Earnings & Revenues Trump Estimates 2025 View Raised. TG Therapeutics beats third-quarter estimates as a surge in Briumvi sales drives revenues up 92.8% and leads to a higher 2025 outlook.

Tue Nov 4, 2025

$33.86 | +0.36%

Earnings

TG Therapeutics Inc. (NASDAQ:TGTX) Q3 2025 Earnings Call Transcript. TG Therapeutics Inc. (NASDAQ:TGTX) Q3 2025 Earnings Call Transcript November 3 2025 TG Therapeutics Inc. beats earnings expectations. Reported EPS is $2.43 expectations were $0.24. Operator: Greetings and welcome to the TG Therapeutics’. Third Quarter Earnings Call and Webcast. [Operator Instructions] Please note this conference is being recorded. I will now turn the conference over [….]

Tue Nov 4, 2025

$33.86 | +0.36%

Earnings

TG Therapeutics raises BRIUMVI 2025 revenue guidance to $585M while advancing subcutaneous pipeline.

Mon Nov 3, 2025

$33.69 | -3.13%

Potential

TG Therapeutics Q3 Earnings: Strong Quarter For Briumvi As CD20 Market Grows.

Mon Nov 3, 2025

$33.69 | -3.13%

Earnings

Highly Watched TG Therapeutics Smashes Profit Views — But Theres A Caveat. TG Therapeutics stock toppled early Monday on a key caveat that undercut the companys massive third-quarter profit beat.The post Highly Watched TG Therapeutics Smashes Profit Views — But There'.s A Caveat appeared first on Investor'.s Business Daily.

Mon Nov 3, 2025

$33.69 | -3.13%

Earnings

TG Therapeutics Reports Third Quarter 2025 Financial Results and Raises BRIUMVI Revenue Guidance. Third quarter 2025 total revenue of $161.7 million including BRIUMVI United States net revenue of $152.9 million

Mon Nov 3, 2025

$33.69 | -3.13%

Potential

Earnings Preview For TG Therapeutics. TG Therapeutics (NASDAQ:) will release its quarterly earnings report on Monday 2025-11-03. Here'.s a brief overview for investors ahead of the announcement.Analysts anticipate TG Therapeutics to report an The announcement from TG Therapeutics is eagerly anticipated with investors seeking news of surpassing estimates and favorable guidance for the next quarter.It'.s worth noting for new investors that guidance can be a key determinant of stock price m

Fri Oct 31, 2025

$34.78 | +2.23%

Earnings

Momentum

FAQ About TGTX Stock Insights

What is TGTX current stock price?

What are TGTX stock strengths?

What risks are associated with TGTX stock?

When is TGTX next earnings report?

What is TGTX market cap and volume?

What is TGTX's current Stock IQ?

Should I buy TGTX stock right now?

Is TGTX a Strong Buy right now?

What does a 'Strong Buy' rating mean for TGTX?

What does a 'Strong Sell' rating mean for TGTX?

What factors influence TGTX's Stock IQ?

Explore our TGTX Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored TGTX Stock Strategies
Effective Risk Management

FIND US ON

Receive our TGTX Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

TGTX

TG Therapeutics

Current Price

$31.11

+$0.81 | +2.67%

52W High

$ 46.48

MKT CAP

$ 4.89B

52W Low

$ 25.28

VOL

$ 1.35M

P/E Ratio

11.2

AVG VOL

$ 1.87M

RSI

36.13

TREND

Sideways

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Target Price

Login to display

Not Enough Information

Stock Insights

Strengths

TGTX Rewards

Earnings are forecast to grow

TGTX Rewards

Expands stock buyback program

TGTX Stock IQ

Login to unlock TG Therapeutics (TGTX) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

Chart

$34.22 (-9.09%)

$28.08 (+10.79%)

$35.17 (-11.54%)

$34.55 (-9.96%)

1year

6month

3month

1month

TGTX Analysts Opinion

TGTX Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

TGTX Analysts Opinion

TGTX Analysts opinion is negative and it remained unchanged from the past 3 months

TGTX Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential.

75%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

NA

0%

100%

TGTX Street Sentiment

TGTX Street Sentiment is extremely bullish and have positive views on the near-term outlook

TGTX Risk Level

TGTX has Moderate risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Risks Indicators

Beta greater than 1.0

Moderate

LOW

HIGH

TGTX Performance Sentiment

Sentiments overview associated with TGTX events and the stock performance.

75%

19%

Positive

Negative

12 out of 16
events present

3 out of 16
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$33.26

Resistance
Price

$32.84

Current Price Range

$35.57

Show methods +

TGTX Latest Analysis

RSI Alert: TG Therapeutics (TGTX) Now Oversold. Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which me

Mon Nov 10, 2025

$30.34 | -6.02%

Technical

TG Therapeutics Crumbles After Roche Unveils Its Unprecedented Test Results.

Mon Nov 10, 2025

$30.34 | -6.02%

Activity

Momentum

Why TG Therapeutics (TGTX) is a Top Growth Stock for the Long-Term. The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Heres why you should take advantage.

Wed Nov 5, 2025

$34.04 | +0.68%

Potential

TGTXs Q3 Earnings & Revenues Trump Estimates 2025 View Raised. TG Therapeutics beats third-quarter estimates as a surge in Briumvi sales drives revenues up 92.8% and leads to a higher 2025 outlook.

Tue Nov 4, 2025

$33.86 | +0.36%

Earnings

TG Therapeutics Inc. (NASDAQ:TGTX) Q3 2025 Earnings Call Transcript. TG Therapeutics Inc. (NASDAQ:TGTX) Q3 2025 Earnings Call Transcript November 3 2025 TG Therapeutics Inc. beats earnings expectations. Reported EPS is $2.43 expectations were $0.24. Operator: Greetings and welcome to the TG Therapeutics’. Third Quarter Earnings Call and Webcast. [Operator Instructions] Please note this conference is being recorded. I will now turn the conference over [….]

Tue Nov 4, 2025

$33.86 | +0.36%

Earnings

TG Therapeutics raises BRIUMVI 2025 revenue guidance to $585M while advancing subcutaneous pipeline.

Mon Nov 3, 2025

$33.69 | -3.13%

Potential

TG Therapeutics Q3 Earnings: Strong Quarter For Briumvi As CD20 Market Grows.

Mon Nov 3, 2025

$33.69 | -3.13%

Earnings

Highly Watched TG Therapeutics Smashes Profit Views — But Theres A Caveat. TG Therapeutics stock toppled early Monday on a key caveat that undercut the companys massive third-quarter profit beat.The post Highly Watched TG Therapeutics Smashes Profit Views — But There'.s A Caveat appeared first on Investor'.s Business Daily.

Mon Nov 3, 2025

$33.69 | -3.13%

Earnings

TG Therapeutics Reports Third Quarter 2025 Financial Results and Raises BRIUMVI Revenue Guidance. Third quarter 2025 total revenue of $161.7 million including BRIUMVI United States net revenue of $152.9 million

Mon Nov 3, 2025

$33.69 | -3.13%

Potential

Earnings Preview For TG Therapeutics. TG Therapeutics (NASDAQ:) will release its quarterly earnings report on Monday 2025-11-03. Here'.s a brief overview for investors ahead of the announcement.Analysts anticipate TG Therapeutics to report an The announcement from TG Therapeutics is eagerly anticipated with investors seeking news of surpassing estimates and favorable guidance for the next quarter.It'.s worth noting for new investors that guidance can be a key determinant of stock price m

Fri Oct 31, 2025

$34.78 | +2.23%

Earnings

Momentum

Discover TGTX Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of TGTX. We're here to help you make informed investment decisions today.

FIND US ON

Receive our TGTX Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

TGTX Stock trends

TGTX Stock performance

TGTX Stock analysis

TGTX investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing TGTX

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing TGTX

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

TGTX Stock Analysis & IQ Rating | TG Therapeutics

TGTX Stock IQ

TGTX Target Price

TGTX Risk Level

TGTX Analysts Opinion

TGTX Street Sentiment

TGTX Performance Sentiment

Technical Price Levels

Explore our TGTX Stock insights

Receive our TGTX Daily Alerts

TGTX Stock IQ

TGTX Street Sentiment

TGTX Risk Level

Technical Price Levels

Discover TGTX Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of TGTX. We're here to help you make informed investment decisions today.

Receive our TGTX Daily Alerts

TGTX Runner Alarm